{"mutation_type":"single base substitution","chromosome":"3","chromosome_start":"77299437","chromosome_end":"77299437","reference_genome_allele":"G","mutation":"G>A","_mutation_id":"MU2","assembly_version":"GRCh37","ssm_occurrence":[{"observation":[{"verification_status":"not tested","platform":"Illumina HiSeq","sequencing_strategy":"WXS"}],"donor":{"donor_sex":"male","donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":null,"donor_tumour_stage_at_diagnosis":"T1c","_donor_id":"DO001","_summary":{"_studies":["PCAWG","STUDY2"],"experimental_analysis_performed":["WGS","miRNA-Seq","WXS","Bisulfite-Seq","RNA-Seq"],"_age_at_diagnosis_group":"40 - 49","_available_data_type":["cnsm","jcn","meth_array","ssm","pexp","stsm","meth_seq","exp_array","sgv","mirna_seq","exp_seq"],"_state":"live"}},"project":{"_project_id":"BRCA-UK","project_name":"Breast Triple Negative/Lobular Cancer - UK","tumour_type":"Breast cancer","tumour_subtype":"Triple Negative/lobular/other","primary_site":"Breast","_summary":{"_ssm_tested_donor_count":2}}}],"transcript":[{"id":"TID2","name":"RP11-1198D22.2-001","biotype":"unprocessed_pseudogene","consequence":{"consequence_type":"transcript_variant","gene_affected":"ENSG00000223749","_gene_id":"GID2","_transcript_id":"TID2","aa_mutation":""},"gene":{"_gene_id":"GID2","biotype":"lincRNA","chromosome":"16","end":34990886,"start":34977639,"strand":1,"symbol":"5S_rRNA","external_db_ids":{},"drug":["ZINC1","ZINC2"],"pathway":["GS2","REACT_111102","REACT_14797","REACT_21268","REACT_21340"],"go_term":{"biological_process":["GS3"]}},"functional_impact_prediction_summary":null},{"id":"TID3","name":"RP11-1198D22.2-001","biotype":"unprocessed_pseudogene","consequence":{"consequence_type":"synonymous_variant","aa_mutation":"L412L","cds_mutation":"1234T>C","gene_affected":"ENSG00000223749","_gene_id":"GID3","_transcript_id":"TID3"},"gene":{"_gene_id":"GID3","biotype":"lincRNA","chromosome":"16","end":34990886,"start":34977639,"strand":1,"symbol":"5S_rRNA","external_db_ids":{},"pathway":["REACT_111102","REACT_14797","REACT_21268","REACT_21340"],"go_term":{"biological_process":["GS3"]}},"functional_impact_prediction_summary":null}],"is_annotated":null,"platform":["Illumina HiSeq"],"validation_status":[],"verification_status":["not tested"],"sequencing_strategy":["WXS"],"consequence_type":["synonymous_variant","transcript_variant"],"functional_impact_prediction_summary":[],"_summary":{"_affected_donor_count":1,"_affected_project_count":1,"_tested_donor_count":2,"_affected_project_id":["BRCA-UK"]}}
{"mutation_type":"single base substitution","chromosome":"3","chromosome_start":"77299437","chromosome_end":"77299437","reference_genome_allele":"G","mutation":"G>A","_mutation_id":"MU1","assembly_version":"GRCh37","ssm_occurrence":[{"observation":[{"verification_status":"not tested","platform":"Illumina HiSeq","sequencing_strategy":"WXS","_study":"pcawg"}],"donor":{"donor_sex":"male","donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":null,"donor_tumour_stage_at_diagnosis":"T1c","_donor_id":"DO001","_summary":{"_studies":["PCAWG","STUDY2"],"experimental_analysis_performed":["WGS","miRNA-Seq","WXS","Bisulfite-Seq","RNA-Seq"],"_age_at_diagnosis_group":"40 - 49","_available_data_type":["cnsm","jcn","meth_array","ssm","pexp","stsm","meth_seq","exp_array","sgv","mirna_seq","exp_seq"],"_state":"live"}},"project":{"_project_id":"BRCA-UK","project_name":"Breast Triple Negative/Lobular Cancer - UK","tumour_type":"Breast cancer","tumour_subtype":"Triple Negative/lobular/other","primary_site":"Breast","_summary":{"_ssm_tested_donor_count":2}}},{"observation":[{"verification_status":"not tested","platform":"Illumina HiSeq","sequencing_strategy":"WXS"}],"donor":{"donor_sex":"male","donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":null,"donor_tumour_stage_at_diagnosis":"T1c","_donor_id":"DO002","_summary":{"_studies":["PCAWG"],"experimental_analysis_performed":[],"_age_at_diagnosis_group":"40 - 49","_available_data_type":["ssm"],"_state":"live"}},"project":{"_project_id":"BRCA-UK","project_name":"Breast Triple Negative/Lobular Cancer - UK","tumour_type":"Breast cancer","tumour_subtype":"Triple Negative/lobular/other","primary_site":"Breast","_summary":{"_ssm_tested_donor_count":2}}}],"transcript":[{"fake":true,"consequence":{"consequence_type":"exon_variant","gene_affected":"GID2","_transcript_id":"","aa_mutation":""},"gene":{"fake":true,"_gene_id":"","symbol":""},"functional_impact_prediction_summary":null},{"id":"TID1","name":"RP11-1198D22.2-001","biotype":"unprocessed_pseudogene","consequence":{"consequence_type":"downstream_gene_variant","gene_affected":"GID2","_gene_id":"GID1","_transcript_id":"TID1","aa_mutation":""},"gene":{"_gene_id":"GID1","biotype":"lincRNA","chromosome":"16","end":34990886,"start":34977639,"strand":1,"symbol":"5S_rRNA","external_db_ids":{},"pathway":["REACT_111102","REACT_14797","REACT_21268","REACT_21340"]},"functional_impact_prediction_summary":null},{"id":"TID2","name":"RP11-1198D22.2-001","biotype":"unprocessed_pseudogene","consequence":{"consequence_type":"3_prime_UTR_variant","gene_affected":"GID3","_gene_id":"GID2","_transcript_id":"TID2","aa_mutation":""},"gene":{"_gene_id":"GID2","biotype":"lincRNA","chromosome":"16","end":34990886,"start":34977639,"strand":1,"symbol":"5S_rRNA","external_db_ids":{},"drug":["ZINC1","ZINC2"],"pathway":["GS2","REACT_111102","REACT_14797","REACT_21268","REACT_21340"],"go_term":{"biological_process":["GS3"]}},"functional_impact_prediction_summary":null}],"is_annotated":null,"platform":["Illumina HiSeq"],"validation_status":[],"verification_status":["not tested"],"sequencing_strategy":["WXS"],"consequence_type":["3_prime_UTR_variant","exon_variant","downstream_gene_variant"],"functional_impact_prediction_summary":[],"_summary":{"_affected_donor_count":2,"_affected_project_count":1,"_tested_donor_count":2,"_affected_project_id":["BRCA-UK"]}}
